title: [The more favourable cost/effectiveness ratio of latanoprost vs bimatoprost and travoprost when using normally for treatment of glaucoma].
authors.forename: J
authors.initials: J
authors.lastname: Soto
mesh_terms: D000577:Amides; D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives* / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005901:Glaucoma / Q000188:drug therapy / Q000191:economics*; D006801:Humans; D000077338:Latanoprost; D008055:Lipids / Q000191:economics*; D009883:Ophthalmic Solutions / Q000191:economics / Q000627:therapeutic use; D011461:Prostaglandins F, Synthetic / Q000191:economics*; D000069557:Travoprost
chemical_list: D000577:Amides; D000959:Antihypertensive Agents; D008055:Lipids; D009883:Ophthalmic Solutions; D011461:Prostaglandins F, Synthetic; D003008:Cloprostenol; D000077338:Latanoprost; D000069580:Bimatoprost; D000069557:Travoprost